Contact Us
  • Home
  • About Us
    • Our Technology
    • Our People
    • Careers
    • News & Events
  • Products & Services
    • Cell Engineering Services
      • Gene Knock-Out
      • Gene Knock-In
      • Stable Cell Line
    • Gene Editing Reagents & Kits
      • piggyBac™
      • CRISPR
      • XTN™ TALEN
      • AAVS1 Safe Harbor Kits
      • Footprint-Free™ Editing Kits
  • Applications
    • Disease Modeling
    • Target ID/Phenotypic Screening
    • Bioproduction
  • Resources
    • Publications
    • Brochures
    • Webinars

News & Events

Home
  • About Us
  • News & Events

Transposagen Issued Key U.S. Patent Covering Rat Models of Cancer

May 15, 2014 9:00:00 AM

/ by Transposagen Biopharmaceuticals

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced the issuing of Patent No. 8,722,964 entitled, “Genetically Engineered or Transgenic Rats Exhibiting a Cancer Phenotype Due to a Disruption of Germline Tumor Suppressor Genes” on May 13th. The patent has terms extending through October 22, 2030.

Read More

Archives

  • June 2015 (1)
  • April 2015 (1)
  • February 2015 (1)
  • November 2014 (1)
  • August 2014 (1)
  • May 2014 (1)
  • April 2014 (1)

Topics

  • News (6)
  • Awards (1)

About Transposagen

Transposagen, Inc. is a privately-held biotechnology company founded in 2003 to commercialize early gene editing technology for the construction of rodent models of disease. Since then, Transposagen has significantly increased its scientific offerings to include a suite of gene editing technologies and services that address the research needs of both academic and drug discovery investigators.

Company Links

  • About Us
  • Products & Services
  • Applications
  • Resources
  • News & Events

Company Info

535 West Second St., Suite 10
Lexington, KY 40508

Phone: (859)-279-4456

Email: info@transposagenbio.com

©2019 Transposagen Biopharmaceuticals, Inc. All Rights Reserved.
Privacy Policy